Table 4.
The prevalence of toxin encoding genes, toxin regulatory genes and toxinotypes in C. perfringens-positive patients with AAD and without AAD.
| Toxin gene | AAD group (n = 68) | Non-AAD group (n = 38) | Total (%) (n = 106) | P value* |
|---|---|---|---|---|
| cpa | 68 (100) | 38 (100) | 106 (100) | |
| cpb | 0 | 0 | 0 | |
| cpb2 | 14 (20.6) | 10 (26.3) | 24 (22.6) | 0.66 |
| etx | 0 | 0 | 0 | |
| iap | 0 | 0 | 0 | |
| cpe | 9 (13.2) | 8 (21) | 17 (16) | 0.44 |
| netB | 0 | 0 | 0 | |
| Toxinotype | ||||
| A | 59 (86.8) | 30 (78.9) | 89 (84) | 0.43 |
| B | 0 | 0 | 0 | |
| C | 0 | 0 | 0 | |
| D | 0 | 0 | 0 | |
| E | 0 | 0 | 0 | |
| F | 9 (13.2) | 8 (21) | 17 (16) | 0.44 |
| G | 0 | 0 | 0 | |
AAD, antibiotic-associated diarrhea.
*Statistical analysis was performed by Chi-square and Fisher’s exact tests.